+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Skin Boosters Market Size, Share & Trends Analysis Report By Type (Mesotherapy, Micro-needle), By Gender (Male, Female), By End-use (Dermatology Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • February 2024
  • Region: Europe
  • Grand View Research
  • ID: 5943905
The Europe skin boosters market is anticipated to reach USD 549.5 million by 2030 and is anticipated to expand at a CAGR of 9.2% during the forecast period. The increasing emphasis on aesthetic appearance and increasing preference towards non-surgical procedures are major driving factors for market growth.

The development of the cosmetic industry in the region is further expected to drive the demand for these products. For instance, according to the statistics published by the British Beauty Council, the cosmetic and personal care sector contributed approximately USD 26.4 billion to the country’s GDP in 2022.

In addition, the initiatives by different governments to ensure the safety of these products and treatments and the launch of technologically advanced products by the global and local players are further expected to drive the demand for various skin boosters. For instance, in January 2023, Galderma launched FACE, an aesthetic visualization application that helps stimulate the results of injectable treatments in real time through digital facial assessments.

Europe Skin Boosters Market Report Highlights

  • Based on type, the mesotherapy segment dominated the market with a revenue share of 54.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period owing to the rising preference for non-surgical cosmetic procedures
  • Based on gender, the female segment dominated the market in terms of revenue share in 2023 and is expected to grow at the fastest CAGR due to the increasing concerns over dermatological conditions among women
  • Based on end use, the medical spas segment dominated the market in terms of revenue share in 2023 owing to the increasing cosmetic procedures in Europe
  • Based on countries, Germany dominated the market in terms of revenue share in 2023 due to the presence of advanced technologies and products in the country
  • In March 2023, CROMA-PHARMA GmbH, a manufacturer of hyaluronic acid (HA) syringes launched PhilArt, a series of injectable skin boosters to further broaden its product portfolio.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Gender
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database.
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Gender outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe Skin Boosters Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Europe Skin Boosters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
Chapter 4. Europe Skin Boosters Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Europe Skin Boosters Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Mesotherapy
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Micro-needle
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Europe Skin Boosters Market: Gender Estimates & Trend Analysis
5.1. Gender Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Europe Skin Boosters Market by Gender Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Male
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Female
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Europe Skin Boosters Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Europe Skin Boosters Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Dermatology Clinics
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Medical Spa
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Europe Skin Boosters Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework/ reimbursement structure
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5.9. Poland
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework/ reimbursement structure
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. AbbVie
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. GALDERMA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merz Pharma
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. CROMA-PHARMA GmbH
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Bloomage Biotech Co., Ltd
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. IBSA Institut Biochimique SA
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Teoxane
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Europe skin boosters market, by type, 2018 - 2030 (USD Million)
Table 3 Europe skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 4 Europe skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 5 Europe skin boosters market, by region, 2018 - 2030 (USD Million)
Table 6 Germany skin boosters market, by type, 2018 - 2030 (USD Million)
Table 7 Germany skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 8 Germany skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 9 UK skin boosters market, by type, 2018 - 2030 (USD Million)
Table 10 UK skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 11 UK skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 12 France skin boosters market, by type, 2018 - 2030 (USD Million)
Table 13 France skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 14 France skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 15 Italy skin boosters market, by type, 2018 - 2030 (USD Million)
Table 16 Italy skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 17 Italy skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 18 Spain skin boosters market, by type, 2018 - 2030 (USD Million)
Table 19 Spain skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 20 Spain skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 21 Norway skin boosters market, by type, 2018 - 2030 (USD Million)
Table 22 Norway skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 23 Norway skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 24 Sweden skin boosters market, by type, 2018 - 2030 (USD Million)
Table 25 Sweden skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 26 Sweden skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 27 Denmark skin boosters market, by type, 2018 - 2030 (USD Million)
Table 28 Denmark skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 29 Denmark skin boosters market, by end-use, 2018 - 2030 (USD Million)
Table 30 Poland skin boosters market, by type, 2018 - 2030 (USD Million)
Table 31 Poland skin boosters market, by gender, 2018 - 2030 (USD Million)
Table 32 Poland skin boosters market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe skin boosters market: market outlook
Fig. 10 Europe skin boosters competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Europe skin boosters market driver impact
Fig. 16 Europe skin boosters market restraint impact
Fig. 17 Europe skin boosters market strategic initiatives analysis
Fig. 18 Europe skin boosters market: Type movement analysis
Fig. 19 Europe skin boosters market: Type outlook and key takeaways
Fig. 20 Mesotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Micro-needle market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Europe skin boosters market: Gender movement analysis
Fig. 23 Europe skin boosters market: Gender outlook and key takeaways
Fig. 24 Male market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Female market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Europe skin boosters market: End-use movement analysis
Fig. 27 Europe skin boosters market: End-use outlook and key takeaways
Fig. 28 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Medical spa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Europe skin boosters market: Regional movement analysis
Fig. 31 Europe skin boosters market: Regional outlook and key takeaways
Fig. 32 Europe skin boosters market share and leading players
Fig. 33 Europe SWOT
Fig. 34 Europe
Fig. 35 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 UK
Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany
Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 France
Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Italy
Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Spain
Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Norway
Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Sweden
Fig. 49 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Denmark
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Poland
Fig. 53 Poland market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • AbbVie
  • GALDERMA
  • Merz Pharma
  • CROMA-PHARMA GmbH
  • Bloomage Biotech Co., Ltd
  • IBSA Institut Biochimique SA
  • Teoxane

Methodology

Loading
LOADING...

Table Information